Medtronic Unveils AI-Powered Touch Surgery™ Aide Platform for Real-Time OR Support — Medtronic plc

Event summary

Medtronic to debut Touch Surgery™ Aide, an AI-native compute platform for operating rooms, at SRS 2026 Annual Meeting (July 23-26).
Platform incorporates NVIDIA's accelerated computing infrastructure for real-time AI during procedures.
First application, Instrument Exit Point (IEP), received FDA clearance for use with Hugo™ RAS system in robotic surgery.
Hugo™ RAS system has been used in tens of thousands of procedures across 35+ countries.

The big picture

Medtronic's launch represents a strategic shift toward AI-native surgical platforms, positioning the company at the forefront of next-generation OR technology. The integration with NVIDIA infrastructure highlights the growing importance of accelerated computing in healthcare innovation. With FDA clearance for its first application and expanding use cases for the Hugo™ RAS system, Medtronic is establishing itself as a key player in the evolving landscape of surgical robotics.

What we're watching

Platform Expansion: Whether Medtronic can successfully expand Touch Surgery™ Aide applications beyond robotic into laparoscopic surgery.
Regulatory Dynamics: The pace at which FDA clears additional AI-powered surgical applications on the platform.
Market Adoption: How quickly hospitals and surgeons integrate real-time AI support into standard operating procedures.